Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis

Yoshiko Kuwabara, Taketo Yamada, Ken Yamazaki, Wen Lin Du, Kouji Banno, Daisuke Aoki, Michiie Sakamoto

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Clinical observations of cases of ovarian metastasis suggest that there may be a unique mechanism underlying ovarian-specific metastasis. This study was undertaken to establish an in vivo model of metastasis to the ovary, and to investigate the mechanism of ovarian-specific metastasis. We examined the capacity for ovarian metastasis in eight different human carcinoma cell lines by implantation in female NOD/SCID mice transvenously and intraperitoneally. By transvenous inoculation, only RERF-LC-AI, a poorly differentiated carcinoma cell line, frequently demonstrated ovarian metastasis. By intraperitoneal inoculation, four of the eight cell lines (HGC27, MKN-45, KATO-III, and RERF-LC-AI) metastasized to the ovary. We compared E-cadherin expression among ovarian metastatic cell lines and others. All of these four ovarian metastatic cell lines and HSKTC, a Krukenberg tumor cell line, showed E-cadherin down-regulation and others did not. E-cadherin was then forcibly expressed in RERF-LC-AI, and inhibited ovarian metastasis completely. The capacity for metastasizing to the other organs was not affected by E-cadherin expression. We also performed histological investigation of clinical ovarian-metastatic tumor cases. About half of all ovarian-metastatic tumor cases showed loss or reduction of E-cadherin expression. These data suggest that E-cadherin down-regulation may be involved in ovarian-specific metastasis.

Original languageEnglish
Pages (from-to)1933-1939
Number of pages7
JournalCancer Science
Volume99
Issue number10
DOIs
Publication statusPublished - 2008

Fingerprint

Cadherins
Down-Regulation
Neoplasm Metastasis
Cell Line
Ovary
Krukenberg Tumor
Carcinoma
Inbred NOD Mouse
SCID Mice
Tumor Cell Line
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis. / Kuwabara, Yoshiko; Yamada, Taketo; Yamazaki, Ken; Du, Wen Lin; Banno, Kouji; Aoki, Daisuke; Sakamoto, Michiie.

In: Cancer Science, Vol. 99, No. 10, 2008, p. 1933-1939.

Research output: Contribution to journalArticle

@article{87a7e48ca77e43059e19257367ecc46a,
title = "Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis",
abstract = "Clinical observations of cases of ovarian metastasis suggest that there may be a unique mechanism underlying ovarian-specific metastasis. This study was undertaken to establish an in vivo model of metastasis to the ovary, and to investigate the mechanism of ovarian-specific metastasis. We examined the capacity for ovarian metastasis in eight different human carcinoma cell lines by implantation in female NOD/SCID mice transvenously and intraperitoneally. By transvenous inoculation, only RERF-LC-AI, a poorly differentiated carcinoma cell line, frequently demonstrated ovarian metastasis. By intraperitoneal inoculation, four of the eight cell lines (HGC27, MKN-45, KATO-III, and RERF-LC-AI) metastasized to the ovary. We compared E-cadherin expression among ovarian metastatic cell lines and others. All of these four ovarian metastatic cell lines and HSKTC, a Krukenberg tumor cell line, showed E-cadherin down-regulation and others did not. E-cadherin was then forcibly expressed in RERF-LC-AI, and inhibited ovarian metastasis completely. The capacity for metastasizing to the other organs was not affected by E-cadherin expression. We also performed histological investigation of clinical ovarian-metastatic tumor cases. About half of all ovarian-metastatic tumor cases showed loss or reduction of E-cadherin expression. These data suggest that E-cadherin down-regulation may be involved in ovarian-specific metastasis.",
author = "Yoshiko Kuwabara and Taketo Yamada and Ken Yamazaki and Du, {Wen Lin} and Kouji Banno and Daisuke Aoki and Michiie Sakamoto",
year = "2008",
doi = "10.1111/j.1349-7006.2008.00946.x",
language = "English",
volume = "99",
pages = "1933--1939",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis

AU - Kuwabara, Yoshiko

AU - Yamada, Taketo

AU - Yamazaki, Ken

AU - Du, Wen Lin

AU - Banno, Kouji

AU - Aoki, Daisuke

AU - Sakamoto, Michiie

PY - 2008

Y1 - 2008

N2 - Clinical observations of cases of ovarian metastasis suggest that there may be a unique mechanism underlying ovarian-specific metastasis. This study was undertaken to establish an in vivo model of metastasis to the ovary, and to investigate the mechanism of ovarian-specific metastasis. We examined the capacity for ovarian metastasis in eight different human carcinoma cell lines by implantation in female NOD/SCID mice transvenously and intraperitoneally. By transvenous inoculation, only RERF-LC-AI, a poorly differentiated carcinoma cell line, frequently demonstrated ovarian metastasis. By intraperitoneal inoculation, four of the eight cell lines (HGC27, MKN-45, KATO-III, and RERF-LC-AI) metastasized to the ovary. We compared E-cadherin expression among ovarian metastatic cell lines and others. All of these four ovarian metastatic cell lines and HSKTC, a Krukenberg tumor cell line, showed E-cadherin down-regulation and others did not. E-cadherin was then forcibly expressed in RERF-LC-AI, and inhibited ovarian metastasis completely. The capacity for metastasizing to the other organs was not affected by E-cadherin expression. We also performed histological investigation of clinical ovarian-metastatic tumor cases. About half of all ovarian-metastatic tumor cases showed loss or reduction of E-cadherin expression. These data suggest that E-cadherin down-regulation may be involved in ovarian-specific metastasis.

AB - Clinical observations of cases of ovarian metastasis suggest that there may be a unique mechanism underlying ovarian-specific metastasis. This study was undertaken to establish an in vivo model of metastasis to the ovary, and to investigate the mechanism of ovarian-specific metastasis. We examined the capacity for ovarian metastasis in eight different human carcinoma cell lines by implantation in female NOD/SCID mice transvenously and intraperitoneally. By transvenous inoculation, only RERF-LC-AI, a poorly differentiated carcinoma cell line, frequently demonstrated ovarian metastasis. By intraperitoneal inoculation, four of the eight cell lines (HGC27, MKN-45, KATO-III, and RERF-LC-AI) metastasized to the ovary. We compared E-cadherin expression among ovarian metastatic cell lines and others. All of these four ovarian metastatic cell lines and HSKTC, a Krukenberg tumor cell line, showed E-cadherin down-regulation and others did not. E-cadherin was then forcibly expressed in RERF-LC-AI, and inhibited ovarian metastasis completely. The capacity for metastasizing to the other organs was not affected by E-cadherin expression. We also performed histological investigation of clinical ovarian-metastatic tumor cases. About half of all ovarian-metastatic tumor cases showed loss or reduction of E-cadherin expression. These data suggest that E-cadherin down-regulation may be involved in ovarian-specific metastasis.

UR - http://www.scopus.com/inward/record.url?scp=54949124206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54949124206&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2008.00946.x

DO - 10.1111/j.1349-7006.2008.00946.x

M3 - Article

C2 - 19016752

AN - SCOPUS:54949124206

VL - 99

SP - 1933

EP - 1939

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 10

ER -